Moderna(IT:1MRNA)
€222.15-6.65 (-2.91%)
IT:1MRNA
Moderna ownership
€222.15
At close:-6.65 (-2.91%)
Moderna (1MRNA) Ownership - Who Owns Moderna?
10 Followers
Moderna (1MRNA) Ownership Overview
- 7.68% Insiders
- 30.13% Mutual Funds
- 5.38% Other Institutional Investors
- 25.76% ETFs
- 31.06% Public Companies and Individual Investors
The ownership structure of Moderna (IT:1MRNA) stock is a mix of institutional, retail, and individual investors. Approximately 61.27% of the company’s stock is owned by Institutional Investors, 7.68% is owned by Insiders, and 31.06% is owned by Public Companies and Individual Investors.
The ownership structure of Moderna (IT:1MRNA) stock is a mix of institutional, retail, and individual investors. Approximately 61.27% of the company’s stock is owned by Institutional Investors, 7.68% is owned by Insiders, and 31.06% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 21, 2026 | Noubar Afeyan | $433,879 | |
| Dec 14, 2025 | Noubar Afeyan | $703,186 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Howard Hughes Medical Institute | €2,211 | |
| Dec 31, 2025 | Goalvest Advisory Llc | €5,160 | |
| Dec 31, 2025 | Wexford Capital Lp | €100,089 | |
| Dec 31, 2025 | Bridgewater Associates, Lp | €447,687 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 37,642,554 | Institution | 9.30% | 9,279,265,987 |
| Vanguard Index Funds | 33,864,244 | Institution | 8.37% | 8,347,874,788 |
| BlackRock, Inc. | 30,599,409 | Institution | 7.56% | 7,543,060,313 |
| Stephane Bancel | 22,215,826 | Insider | 5.49% | 5,476,423,267 |
| Ishares | 19,378,586 | Institution | 4.79% | 4,777,015,235 |
| Invesco | 16,026,707 | Institution | 3.96% | 3,950,743,543 |
| Spdr | 15,473,734 | Institution | 3.82% | 3,814,430,168 |
| Growth Fund Of America | 14,983,229 | Institution | 3.70% | 3,693,515,781 |
| Fidelity Mt. Vernon Street Trust | 13,018,070 | Institution | 3.22% | 3,209,084,436 |
| Patrick Degorce | 8,057,571 | Institution | 1.99% | 1,986,271,827 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 33,864,244 | Institution | 8.37% | 8,347,874,788 |
| Growth Fund Of America | 14,983,229 | Institution | 3.70% | 3,693,515,781 |
| Fidelity Mt. Vernon Street Trust | 13,018,070 | Institution | 3.22% | 3,209,084,436 |
| Fidelity Securities Fund | 7,791,844 | Institution | 1.93% | 1,920,767,464 |
| Fidelity Concord Street Trust | 7,031,397 | Institution | 1.74% | 1,733,309,674 |
| Fidelity Contrafund | 5,975,682 | Institution | 1.48% | 1,473,065,370 |
| Vanguard World Fund | 5,958,852 | Institution | 1.47% | 1,468,916,607 |
| Fidelity Select Portfolios | 2,736,729 | Institution | 0.68% | 674,631,066 |
| Fidelity Puritan Trust | 2,355,389 | Institution | 0.58% | 580,626,942 |
| Vanguard Specialized Funds | 2,345,644 | Institution | 0.58% | 578,224,702 |
FAQ
Who Owns Moderna (IT:1MRNA)?
According to the latest TipRanks data, approximately 61.27% of the company's stock is held by institutional investors, 7.68% is held by insiders, and 31.06% is held by public companies and individual investors.
What percentage of Moderna (IT:1MRNA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 61.27% of Moderna (IT:1MRNA) stock is held by institutional investors: 30.13% by mutual funds, 25.76% by ETFs and 5.38% by other institutional investors.
What percentage of Moderna (IT:1MRNA) stock is held by retail investors?
According to the latest TipRanks data, approximately 31.06% of Moderna (IT:1MRNA) stock is held by public companies and individual investors.
Who owns the most shares of Moderna (IT:1MRNA)?
Vanguard owns the most shares of Moderna (IT:1MRNA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
